Nuvation Bio Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Nuvation Bio Inc. (NUVB) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 20.10 million shares for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-04.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-05-04
- Nuvation Bio Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 20.10M shares, a 77.03% decline year-over-year.
- Nuvation Bio Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 87.50M shares, a 59042.00% increase year-over-year.
- Nuvation Bio Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 147.95K shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|
| 2026-03-31 | 20.10M shares 10-Q · filed 2026-05-04 | |
| 2025-03-31 | 87.50M shares 10-Q · filed 2026-05-04 | |
| 2024-03-31 | 147.95K shares 8-K/A · filed 2024-06-20 | |
| 2023-12-31 | 140.37K shares 8-K/A · filed 2024-06-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B |